• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

ACE-inhibitors and statins do not impact albuminuria in adolescents with type 1 diabetes mellitus: The AdDIT trial

byJames RoebkerandDayton McMillan
November 7, 2017
in Cardiology, Chronic Disease, Endocrinology, Nephrology, Neurology, Ophthalmology, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In adolescents with type 1 diabetes mellitus, the albumin-to-creatinine ratio was not significantly changed by angiotensin-converting-enzyme (ACE) inhibitors alone, statins alone, or the two in combination compared to placebo.

2. In this population, ACE-inhibitors and statins did not demonstrate a significant benefit on other markers of diabetic vascular complications including the glomerular filtration rate (GFR), blood pressure, or carotid intima-media thickness.

Evidence Rating Level: 1 (Excellent)   

Study Rundown: The development of vascular complications in type 1 diabetes is known to begin in adolescence despite the lack of clinical manifestations until adulthood. Albuminuria is a validated early marker for nephropathy and correlates with other vascular complications of diabetes. The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT) investigated whether ACE-inhibitors and statins alone or in combination reduced albuminuria and would be an effective intervention to reduce the incidence of future vascular complications in adolescents with type 1 diabetes. The primary outcome, a change in the albumin-to-creatinine ratio, was not significantly affected by ACE-inhibitors alone, statins alone, or the two in combination. Among key secondary outcomes, including microalbuminuria, lipid levels, carotid intima-media thickness, blood pressure, GFR, levels of high-sensitivity C-reactive protein, and asymmetric dimethylarginine, the only significant effect was a reduction in non-HDL lipids in the group treated with statins. The incidence of adverse events was similar between all groups. While additional follow-up is needed to assess potential long-term effects, this study suggests early intervention with ACE-inhibitors and statins in adolescents with type 1 diabetes is not beneficial.

This double-blind, randomized, placebo-controlled trial was adequately powered to observe a significant change in the albumin-to-creatinine ratio based on previously published data. It provides evidence on ACE-inhibitors and statins in the diabetic adolescent population which has little data compared to adults. A major limitation is the short-duration of the trial relative to the time it takes to develop vascular complications in diabetes.

Click to read the study in NEJM

Relevant Reading: Early atherosclerosis related to urinary albumin excretion and cardiovascular risk factors in adolescents with type 1 diabetes: adolescent type 1 diabetes cardio-renal intervention trial (AdDIT)

RELATED REPORTS

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

Low- and no-calorie sweetened beverages associated with reduced body weight compared to sugar-sweetened beverages: a systematic review and meta-analysis

In-Depth [randomized controlled trial]: From May 2009 through August 2013, 443 adolescents aged 10-16 with a Âł1 year diagnosis of type 1 diabetes and albumin-to-creatinine ratio in the upper third of a screened population of 4407 patients underwent randomization to ACE-inhibitor (quinapril at a dose of 5 to 10 mg daily) and placebo, statin (atorvastatin at a dose of 10 mg daily) and placebo, ACE-inhibitor and statin, or placebo and placebo groups. Urine and blood samples were taken every 6 months, with final assessments occurring after a minimum of 2 years and maximum of 4 years. The median follow-up was 2.6 years (range, 0.1 to 4.4).

Neither ACE-inhibitors (effect, -0.01; 95% confidence interval [CI], -0.05 to 0.03) or statins (0.01; 95% CI, -0.02 to 0.05) alone or in combination (0.04; 95% CI, -0.04 to 0.12) had a significant effect on the area under the curve (AUC) of the albumin-to-creatinine ratio. Among secondary outcomes, ACE-inhibitors demonstrated no reduction in microalbuminuria (p = 0.046, non-significant when analyzed for negative findings) with an adjusted hazard ratio [HR] of 0.57 (95% CI, 0.35 to 0.94; p = 0.03). Statin treatment was associated with lower total, LDL, and non-HDL cholesterol. There were no significant effects of either ACE-inhibitors or statins on carotid intima-media thickness or asymmetric dimethylarginine levels. Statins led to a non-significant reduction in levels of high-sensitivity C-reactive protein. A patient’s ACE-inhibitor dose was reduced in 56/222 patients (25%) due to postural hypotension. Four serious adverse events were found to be related to ACE-inhibitor treatment (two significant reductions in GFR, a hypotensive episode, and an elevation in alanine aminotransferase). No serious adverse events were found related to statin therapy.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular riskdiabetes mellitusDiabetic NephropathyDiabetic Neuropathiesdiabetic retinopathytype 1 diabetes
Previous Post

2 Minute Medicine Rewind November 6, 2017

Next Post

High intensity specialized intervention content following family-based intervention yields improved childhood weight loss

RelatedReports

FDA-approved weight loss medications associated with weight loss at one year
Cardiology

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

May 25, 2022
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Cardiology

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

April 7, 2022
Added sugar intake associated with mortality from cardiovascular disease
Cardiology

Low- and no-calorie sweetened beverages associated with reduced body weight compared to sugar-sweetened beverages: a systematic review and meta-analysis

March 16, 2022
Blindness and visual impairment decreasing worldwide
Chronic Disease

Faricimab may improve visual acuity in patients with diabetic macular edema

March 8, 2022
Next Post
Sleep duration inversely related to childhood type 2 diabetes risk makers

High intensity specialized intervention content following family-based intervention yields improved childhood weight loss

Rapid genetic testing useful for diagnosis of critically ill children

Preterm birth with small for gestational age status may increase mortality

Adaptive interim PET-CT guides treatment for advanced Hodgkin’s lymphoma

Anti-TNF agents and thiopurines are associated with a slight increase in lymphoma in IBD patients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.